Table 2.
RR for OS, PFS, and EFS at 8 Years and Cumulative Incidences of CCyR, MMR, and CMR According to the Transcript Level at 3, 6, and 12 Months
Outcome | RR for Transcript Level (Log) |
Cutoff (%) | No. of Patients at Risk | 8-Year Probability of the Outcome |
8-Year Probability of the Outcome According to Risk Group |
||||
---|---|---|---|---|---|---|---|---|---|
RR | P | % | P | No. of Patients | % | P | |||
BCR-ABL1 transcript level at 3 months | |||||||||
OS | 0.161 | < .001 | < .001 | ||||||
Low risk | ≤ 9.84 | 211 | 93.3 | N/A | N/A | ||||
High risk | > 9.84 | 68 | 56.9 | N/A | N/A | ||||
PFS | 0.162 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 9.54 | 208 | 92.8 | 211 | 92.8 | ||||
High risk | > 9.54 | 71 | 57.0 | 68 | 55.5 | ||||
EFS | 0.102 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 9.84 | 211 | 65.1 | 211 | 65.1 | ||||
High risk | > 9.84 | 66 | 6.9 | 66 | 6.9 | ||||
CCyR | 5.17 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 8.58 | 169 | 99.4 | 180 | 97.9 | ||||
High risk | > 8.58 | 79 | 21.7 | 68 | 14.8 | ||||
MMR | 12.98 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 2.81 | 141 | 82.5 | 210 | 70.1 | ||||
High risk | > 2.81 | 137 | 21.1 | 68 | 0 | ||||
CMR | 10.95 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 0.61 | 57 | 84.7 | 211 | 19.3 | ||||
High risk | > 0.61 | 222 | 1.5 | 68 | 0 | ||||
BCR-ABL1 transcript level at 6 months | |||||||||
OS | 0.342 | < .001 | < .001 | N/A | N/A | ||||
Low risk | ≤ 1.67 | 187 | 93.7 | N/A | N/A | ||||
High risk | > 1.67 | 87 | 74.7 | ||||||
PFS | 0.328 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 1.73 | 188 | 92.8 | 187 | 92.8 | ||||
High risk | > 1.73 | 86 | 68.9 | 87 | 69.4 | ||||
EFS | 0.195 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 1.67 | 186 | 70.7 | 186 | 70.7 | ||||
High risk | > 1.67 | 87 | 18.3 | 87 | 18.3 | ||||
CCyR | 5.033 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 2.70 | 98 | 92.0 | 82 | 93.9 | ||||
High risk | > 2.70 | 66 | 24.7 | 82 | 35.8 | ||||
MMR | < .001 | < .001 | |||||||
Low risk | 6.854 | < .001 | ≤ 0.73 | 136 | 81.6 | 176 | 72.5 | ||
High risk | > 0.73 | 123 | 20.4 | 83 | 13.9 | ||||
CMR | 4.405 | < .001 | < .001 | .006 | |||||
Low risk | ≤ 0.21 | 73 | 42.7 | 187 | 21.0 | ||||
High risk | > 0.21 | 197 | 6.1 | 83 | 4.0 | ||||
BCR-ABL1 transcript level at 12 months | |||||||||
OS | 0.398 | < .001 | < .001 | N/A | N/A | ||||
Low risk | ≤ 0.53 | 164 | 95.4 | N/A | N/A | ||||
High risk | > 0.53 | 93 | 74.7 | ||||||
PFS | 0.333 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 0.53 | 164 | 94.9 | 164 | 94.9 | ||||
High risk | > 0.53 | 92 | 73.1 | 92 | 73.1 | ||||
EFS | 0.280 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 0.57 | 168 | 82.1 | 164 | 75.0 | ||||
High risk | > 0.57 | 78 | 41.4 | 82 | 27.6 | ||||
MMR | 5.639 | < .001 | < .001 | < .001 | |||||
Low risk | ≤ 0.22 | 90 | 81.6 | 121 | 78.4 | ||||
High risk | > 0.22 | 114 | 20.4 | 83 | 12.3 | ||||
CMR | 4.139 | < .001 | < .001 | .005 | |||||
Low risk | ≤ 0.036 | 59 | 52.1 | 158 | 18.8 | ||||
High risk | > 0.036 | 182 | 4.1 | 83 | 4.1 |
NOTE. Table shows the cutoff in transcript levels that distinguishes low-risk and high-risk groups with maximal sensitivity and specificity for each outcome, the 8-year probability of outcome in each of the two groups created by applying the cutoffs identified for each outcome, and the 8-year probabilities for the various outcomes according to the risk group defined by OS.
Abbreviations: CCyR, complete cytogenetic response; CMR, complete molecular response; EFS, event-free survival; MMR, major molecular response; OS, overall survival; PFS, progression-free survival; RR, relative risk.